Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 4, 1996, Pages 424-434

  Sullivan, Janice E ^b   Witte, Madolin K ^c   Yamashita, Toyoko S ^d   Myers, Carolyn M ^d   Blumer, Jeffrey L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE;

AGE; ARTICLE; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; DIURESIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EXCRETION; ELECTROLYTE EXCRETION; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MICTURITION; NEWBORN; OSMOLALITY; PHARMACODYNAMICS; PRIORITY JOURNAL;

BUMETANIDE; CRITICAL ILLNESS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROLYTES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES; URINATION;

EID: 0029966882     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90199-X     Document Type: Article

References (39)

1. Baliga R, Lewy JE. Pathogenesis and treatment of edema. Pediatr Clin North Am 1987;34:639-48.
2. Hock RL, Anderson RJ. Use - and abuse - of diuretics in the ICU. J Crit Illness 1991;6:1095-1107.
3. Witte MK, Stork JE, and Blumer JL. Diuretic therapeutics in the pediatric patient. Am J Cardiol 1986; 57:44A-53A.
4. Narins RG, Chusid P. Diuretic use in critical care. Am J Cardiol 1986;57:26A-32A.
5. Ramsay LE, McInnes GT, Hettiarachchi J, Shelton J, Scott P. Bumetanide and furosemide: a comparison of dose-response curves in healthy men. Br J Clin Pharmacol 1978;5:243-7.
6. Asbury MJ, Gatenby PBB, O'Sullivan S, Bourke E. Bumetanide: potent new "loop" diuretic. Br Med J 1972;1:211-3.
7. Bourke E. Furosemide, bumetanide, and ototoxicity. Lancet 1976;1:917-8.
8. Brown RD, Manno JE, Daigneault EA, Manno BR. Comparative acute ototoxicity of intravenous bumetanide and furosemide in the pure-bred beagle. Toxicol Appl Pharmacol 1979;48:157-69.
9. Dunn FG, Kerr IC, McQueen MJ, Thomson RM. Comparison of intravenous bumetanide and furosemide during open heart surgery. Postgrad Med 1975;51(suppl 6):72-6.
10. Ward OC, Lam LKT, Bumetanide in heart failure in infancy. Arch Dis Child 1977;52:877-82.
11. Sullivan JE, Witte MK, Yamashita TS, Myers C, Blumer JL. Pharmacokinetics of bumetanide in critically ill children. Clin Pharmacol Ther 1996;60:405-13.
12. Hammarlund MM, Odlind B, Paalzow LK. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 1985;233:447-53.
13. Brater DC. Clinical pharmacology of loop diuretics. Drugs 1991;41(suppl 3):14-22.
14. Hammarlun-Udenaes M, Benet L. Furosemide pharmacokinetics and pharmacodynamics in health and disease - an update. J Pharmacokinet Biopharm 1989; 17:1-46.
15. Schwartz, MA. Metabolism of bumetanide. J Clin Pharmacol 1981;21:555-63.
16. Lau HS, Shih LJ, Smith DE. Effect of probenecid on the dose-response relationship of bumetanide at steady state. J Pharmacol Exp Ther 1983;227:51-4.
17. Puschett, JB. Renal effects of bumetanide. J Clin Pharmacol 1981;21:575-80.
18. Chennavasin P, Seiwell R, Brater DC, Liang WMM. Pharmacodynamic analysis of the furosemide-probenecid interaction in man. Kidney Int 1979;16: 187-95.
19. Andreasen F, Lauridsen N[swsl]orager I, Hansen F, Christensen S, Steiness E. Dose dependency of furosemide-induced sodium excretion. J Pharmacol Exp Ther 1989;248:1182-8.
20. Brater DC. Diuretic pharmacokinetics and pharmacodynamics. In: van Boxtel CJ, Holford NHG, Danhof M, editors. The in vivo study of drug action. New York: Elsevier Science Publishers, 1992:253-75.
21. Jayakumar S, Puschett KB. Study of the sites and mechanisms of action of bumetanide in man. J Pharmacol Exp Ther 1977;201:251-8.
22. Odlind B. Determinants of access of diuretics to their site of action. Fed Proc 1983;42:1703-6.
23. Spector R. Bumetanide, loop diuretic. Iowa Med 1987;77:127-31.
24. Odlind B. Coupling between renal tubular secretion and effect of bumetanide. Clin Pharmacol Ther 1983; 34:805-9.
25. Kaojarern S, Day B, Brater DC. The time course of delivery of furosemide into urine: an independent determinant of overall response. Kidney Int 1982;22:69-74.
26. Burg M, Stoner LC, Cardinal J, Green N. Furosemide effect on isolated perfused tubules. Am J Physiol 1973;255:119-24.
27. Wells TG, Fasules JW, Taylor BJ, Kearns GL. Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr 1992;121:974-80.
28. Walker PC, Szhuthachan S, Desai R. Effects of single dose bumetanide in premature neonates [abstract]. Pediatr Res 1988;23:265A.
29. Gale R, Armon Y, Aranda JV. Pharmacodynamic profile of bumetanide in newborn infants [abstract]. Pediatr Res 1988;23:257A.
30. Vargo D, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC. The pharmacodynamics of torsemide in patients with congestive heart failure. Clin Pharmacol Ther 1994;56:48-54.
31. Rudy DW, Gehr TWB, Matzke GR, Kramer WG, Sica DA, Brater DC. The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency. Clin Pharmacol Ther 1994;56:39-47.
32. Passmore AP, Whitehead EM, Johnston GD. Comparison of the acute renal and peripheral vascular responses to furosemide and bumetanide at low and high doses. Br J Clin Pharmacol 1989;27:305-12.
33. Olsen UB. The pharmacology of bumetanide. Acta Pharmacol Toxicol 1977;41(suppl 3):3-25.
34. Puschett JB. Sites and mechanisms of action of diuretics in the kidney. J Clin Pharmacol 1981;21:564-74.
35. Burg M, Stoner L. Sodium transport in the distal nephron. Fed Proc 1974;33:31-6.
36. Lee SH, Lee MG, Earn ND. Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: absorption from various GI segments. J Pharmacokinet Biopharm 1994;22:1-17.
37. De Rouffignac C, Quamme G. Renal magnesium handling and its hormonal control. Physiol Rev 1994;74: 305-22.
38. Lee MG, Tun Li, Chiou WL. Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide. Biopharm Drug Dispos 1986;7:537-47.
39. Singh NC, Kissoon N, Mofada S, Bennett M, Bohn DJ. Comparison of continuous versus intermittent furosemide administration in postoperative pediatric cardiac patients. Crit Care Med 1992;20:17-21.